Parallax Volatility Advisers’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-66
Closed -$3K 3167
2021
Q2
$3K Buy
+66
New +$2.92K ﹤0.01% 2856
2019
Q1
Sell
-8,494
Closed -$138K 3261
2018
Q4
$124K Buy
+8,494
New +$136K ﹤0.01% 1879
2018
Q1
Sell
-18,270
Closed -$354K 3057
2017
Q4
$370K Buy
+18,270
New +$336K ﹤0.01% 1753
2017
Q2
Sell
-5,929
Closed -$79.2K 2938
2017
Q1
$77K Buy
+5,929
New +$74.9K ﹤0.01% 2386

Other funds holding HALO

Parallax Volatility Advisers's HALO Position: Q3 2021 in Review

Parallax Volatility Advisers sold out of Halozyme (HALO) in Q3 2021, closing a stake of 66 shares — an estimated $3K sold.

Parallax Volatility Advisers first reported a position in HALO in Q1 2017 and held it in 4 quarters. The position peaked at $370K in Q4 2017. 325 funds tracked by Wall St. Rank hold HALO as of Q3 2021.

  • Parallax Volatility Advisers reported no remaining Halozyme position as of Q3 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 66 Halozyme shares in Q3 2021, an estimated $3K.
  • Parallax Volatility Advisers first reported a position in Halozyme in Q1 2017 and held it in 4 quarters.
  • Parallax Volatility Advisers's Halozyme position peaked at $370K in Q4 2017.
  • 325 funds tracked by Wall St. Rank held Halozyme as of Q3 2021.

Based on Parallax Volatility Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.